Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9776385rdf:typepubmed:Citationlld:pubmed
pubmed-article:9776385lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:9776385lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9776385lifeskim:mentionsumls-concept:C0040616lld:lifeskim
pubmed-article:9776385lifeskim:mentionsumls-concept:C1704410lld:lifeskim
pubmed-article:9776385lifeskim:mentionsumls-concept:C1373060lld:lifeskim
pubmed-article:9776385lifeskim:mentionsumls-concept:C0870432lld:lifeskim
pubmed-article:9776385lifeskim:mentionsumls-concept:C1705417lld:lifeskim
pubmed-article:9776385lifeskim:mentionsumls-concept:C1555465lld:lifeskim
pubmed-article:9776385lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:9776385lifeskim:mentionsumls-concept:C0214185lld:lifeskim
pubmed-article:9776385pubmed:issue7lld:pubmed
pubmed-article:9776385pubmed:dateCreated1999-1-7lld:pubmed
pubmed-article:9776385pubmed:abstractTextThe nitric oxide synthase inhibitor 7-nitroindazole (7-NI) dose-dependently (3.0-30.0 mg/kg) displayed anxiolytic activity, as measured by an increase in open arm exploration time in the elevated plus-maze (EPM), following intraperitoneal (i.p.) administration in rats. Acute administration of 7-NI at 30.0 mg/kg significantly (P < 0.05) increased open arm exploration time by 176% compared to vehicle control, similar to the benzodiazepine diazepam at 1.0 and 3.0 mg/kg (+ 191 and + 200%, respectively). However, 39 h following subchronic 5-day administration of diazepam twice daily (bid) at 3.0 mg/kg, diazepam was devoid of anxiolytic activity at 1.0 mg/kg, as measured by no difference in open arm exploration time compared to vehicle control, while the 3.0 mg/kg dose still produced a significant (P < 0.05) 175% increase in open arm exploration time. In contrast, following subchronic administration of 7-NI (30.0 mg/kg, bid), a significant (P < 0.01) enhancement in open arm exploration time was observed at 30.0 mg/kg (+ 665% compared to control). Therefore, inhibition of nitric oxide synthase by 7-NI resulted in anxiolysis similar to diazepam following acute administration in the EPM. However, following subchronic administration, unlike diazepam which showed an attenuation of anxiolytic activity, 7-NI displayed enhanced anxiolytic efficacy and was devoid of tolerance.lld:pubmed
pubmed-article:9776385pubmed:languageenglld:pubmed
pubmed-article:9776385pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9776385pubmed:citationSubsetIMlld:pubmed
pubmed-article:9776385pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9776385pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9776385pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9776385pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9776385pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9776385pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9776385pubmed:statusMEDLINElld:pubmed
pubmed-article:9776385pubmed:monthJullld:pubmed
pubmed-article:9776385pubmed:issn0028-3908lld:pubmed
pubmed-article:9776385pubmed:authorpubmed-author:ReedT ATAlld:pubmed
pubmed-article:9776385pubmed:authorpubmed-author:FrydC HCHlld:pubmed
pubmed-article:9776385pubmed:authorpubmed-author:DunnR WRWlld:pubmed
pubmed-article:9776385pubmed:authorpubmed-author:CopelandP DPDlld:pubmed
pubmed-article:9776385pubmed:issnTypePrintlld:pubmed
pubmed-article:9776385pubmed:volume37lld:pubmed
pubmed-article:9776385pubmed:ownerNLMlld:pubmed
pubmed-article:9776385pubmed:authorsCompleteYlld:pubmed
pubmed-article:9776385pubmed:pagination899-904lld:pubmed
pubmed-article:9776385pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:meshHeadingpubmed-meshheading:9776385-...lld:pubmed
pubmed-article:9776385pubmed:year1998lld:pubmed
pubmed-article:9776385pubmed:articleTitleThe nitric oxide synthase inhibitor 7-nitroindazole displays enhanced anxiolytic efficacy without tolerance in rats following subchronic administration.lld:pubmed
pubmed-article:9776385pubmed:affiliationNOS/CETS, Old Lyme, CT 06371, USA.lld:pubmed
pubmed-article:9776385pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9776385pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9776385pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:9776385pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9776385lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9776385lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9776385lld:pubmed